A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Clinical trial NCT06774131 · RECRUITING

Trial details

NCT number: NCT06774131
Sponsor: UroGen Pharma Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Upper Urinary Tract Urothelial Carcinoma Urothelial Carcinoma

Start date: 2025-08-06
Primary completion: 2027-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.